Gastroenterology Update from NEJM

The New England Journal of Medicine
View in browser
Advertisement
User Icon  GUSTAVO BRASLAVSKY
Subscribe
NEJM Logo
Gastroenterology Update
October 2024
Original Research
Original Article  |  Sep 26, 2024  |  Video
Phase 2 Trial of Anti-TL1A Monoclonal Antibody Tulisokibart for Ulcerative Colitis
B.E. Sands and Others
Phase 2 Trial of Tulisokibart for Ulcerative Colitis
Quick Take
Phase 2 Trial of Tulisokibart for Ulcerative Colitis
Original Article  |  Sep 14, 2024
Ponsegromab for the Treatment of Cancer Cachexia
J.D. Groarke and Others
Editorial NEJM at ESMO — Ponsegromab in Cancer Cachexia
Original Article  |  Sep 14, 2024
Preoperative Chemoradiotherapy for Resectable Gastric Cancer
T. Leong and Others
Editorial NEJM at ESMO — Preoperative Chemoradiotherapy for Resectable Gastric Cancer
Original Article  |  Sep 10, 2024
Liraglutide for Children 6 to <12 Years of Age with Obesity — A Randomized Trial
C.K. Fox and Others
Editorial Childhood Obesity and GLP-1 Receptor Agonists — A Coming of Age?
Original Article  |  Sep 10, 2024
Insulin Efsitora versus Degludec in Type 2 Diabetes without Previous Insulin Treatment
C. Wysham and Others
Editorial A New Once-Weekly Insulin — Its Effectiveness and Safety
Correspondence  |  Sep 26, 2024
Zolbetuximab in Gastric or Gastroesophageal Junction Adenocarcinoma
Editorial NEJM at ESMO — Zolbetuximab in Gastric or Gastroesophageal Junction Adenocarcinoma
Correspondence  |  Sep 14, 2024
Pembrolizumab in HER2-Positive Gastric Cancer
Editorial NEJM at ESMO — Pembrolizumab in HER2+ Gastric Cancer
 
Clinical Practice and Review
Review Article  |  Sep 05, 2024  |  CME
Pancreatic Cysts
T.A. Gonda, D.L. Cahen, and J.J. Farrell
 
Multimedia
Multimedia 1
Images in Clinical Medicine
Angioedema of the Intestines
 
Perspective and Commentary
Perspective  |  Sep 28, 2024
Caring for Our Communities
S. Sankaran
Editorial  |  Sep 26, 2024  |  FREE  |  Audio
NEJM at ESMO — Zolbetuximab in Gastric or Gastroesophageal Junction Adenocarcinoma
E.J. Rubin, O.O. Yeku, and S. Morrissey
Medium Rect Ad
Clinical Implications of Basic Research  |  Sep 25, 2024
Reactivation of SOX17 Program as Immune-Evasion Mechanism in Early Colorectal Cancer Development
A. Ahadova and M. Kloor
Clinical Implications of Basic Research  |  Sep 19, 2024
Discovery of GLP-1–Based Drugs for the Treatment of Obesity
D.J. Drucker
Editorial  |  Sep 14, 2024  |  FREE  |  Audio
NEJM at ESMO — Preoperative Chemoradiotherapy for Resectable Gastric Cancer
E.J. Rubin, O.O. Yeku, and S. Morrissey
Editorial  |  Sep 14, 2024  |  FREE  |  Audio
NEJM at ESMO — Ponsegromab in Cancer Cachexia
E.J. Rubin, O.O. Yeku, and S. Morrissey
Editorial  |  Sep 14, 2024  |  FREE  |  Audio
NEJM at ESMO — Pembrolizumab in HER2+ Gastric Cancer
E.J. Rubin, O.O. Yeku, and S. Morrissey
Perspective  |  Sep 12, 2024  |  FREE  |  Audio
Intention to Treat: What Exactly Is Long Covid? — ITT Episode 37
Clinical Decisions  |  Sep 12, 2024  |  Poll
Medication for Gastroesophageal Reflux Disease in Infants
J.R. Barzilay, M.T. Stein, and P. Heimberg
Perspective  |  Sep 12, 2024
Ingesting Risk — The FDA and New Food Ingredients
P.A. Cohen and E.M. Broad Leib
Editorial  |  Sep 10, 2024
A New Once-Weekly Insulin — Its Effectiveness and Safety
I. Brodsky
 
Keep up with NEJM Evidence
NEJM Evidence This Week
A weekly email newsletter with the latest original research and fresh ideas for clinical trial design and clinical decisions, including information about the latest issue of NEJM Evidence.
Sign Up Now  Arrow
Subscribe to the New England Journal of Medicine
The New England Journal of Medicine delivers the most significant, most clinically relevant research in medicine. Advance your knowledge with the information you trust to stay informed and improve patient care. Your subscription includes 52 weeks of NEJM.org access, 50 FREE article views from the NEJM Archive (1812-1989), and free access to all NEJM Weekly CME activities (choose from over 350).
Subscribe Today  Arrow
Home Promo Ad
NEJM Career Center
PHYSICIAN JOBS
Gastroenterology
Various Gastroenterology Specialists - Long Island
New York
Gastroenterology
Gastroenterologist - Nexus Health Santa Fe
Santa Fe, New Mexico
Looking for a new practice opportunity? View these jobs and other listings at
NEJM CareerCenter
FOLLOW US
Facebook Twitter Instagram LinkedIn YouTube
This email was sent to gustavo.braslavsky@gmail.com
To stop receiving these emails, unsubscribe from NEJM Gastroenterology Alert. Sign in to update preferences or sign up for additional email alerts. Did this email get forwarded to you? Sign up here.
To ensure you always receive NEJM Gastroenterology Alert, add alerts@n.nejm.org to your Contacts or Address Book.
The New England Journal of Medicine • 860 Winter Street • Waltham, MA 02451USA
Copyright © 2024 Massachusetts Medical Society. All rights reserved.
NEJM Group

No comments: